Virologic Failure in First-Line Human Immunodeficiency Virus Therapy with a CCR5 Entry Inhibitor, Aplaviroc, plus a Fixed-Dose Combination of Lamivudine-Zidovudine: Nucleoside Reverse Transcriptase Inhibitor Resistance Regardless of Envelope Tropism
Demarest, J. F., Amrine-Madsen, H., Irlbeck, D. M., Kitrinos, K. M.Volume:
53
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01055-08
Date:
March, 2009
File:
PDF, 569 KB
english, 2009